獸用感染疾病物市場規模、佔有率和成長分析：按產品類型、動物類型、給藥途徑、分銷管道、最終用戶和地區分類－2026-2033年產業預測

2024 年全球獸用感染疾病物市場價值為 86 億美元，預計從 2025 年的 92.2 億美元成長到 2033 年的 160.8 億美元，預測期（2026-2033 年）的複合年成長率為 7.2%。

全球獸用感染疾病物市場的主要驅動力是牲畜和伴侶動物對有效感染疾病控制日益成長的需求。該市場涵蓋多種產品，包括抗生素、抗病毒藥物、抗真菌藥物和診斷試劑，這些產品對於維護動物健康至關重要，直接影響糧食安全、公共衛生和經濟生計。農業集約化和寵物數量的增加推動了該行業的成長，刺激了製藥業的創新和監管力度的加強。影響市場動態的關鍵因素包括抗菌素抗藥性所帶來的挑戰及其對獸醫的影響。隨著抗藥性的加劇，對快速診斷、窄頻譜藥物和替代治療方法的需求不斷成長，同時，人工智慧驅動的進步也在不斷推進，以增強診斷能力並促進抗菌藥物的合理使用。

全球獸用感染疾病物市場的成長要素

全球獸用感染疾病物市場的主要促進因素之一是家畜和伴侶動物感染疾病的日益普及。寵物飼主和畜牧養殖戶對動物健康和福利意識的提高，推動了對有效治療方法的需求。此外，旨在改善動物健康的法規的製定，以及由於對富含蛋白質的飼料的需求而推動的畜牧業發展，也顯著增加了對獸用感染疾病物的需求。新療法研發的進展也促進了市場成長，有助於應對抗生素抗藥性挑戰，並滿足對替代療法的需求。

全球獸用感染疾病物市場的限制因素

全球獸用感染疾病物市場的主要限制因素之一是抗菌素抗藥性（AMR）的日益嚴重。抗藥性菌株在人類和獸醫領域的傳播對現有抗感染疾病療法的有效性構成了重大挑戰。這不僅限制了獸醫有效控制感染疾病的選擇，也引發了公眾健康和食品安全的擔憂。監管機構正在對抗菌藥物的核准和使用進行日益嚴格的審查，從而加強了相關法規和指南。這些因素可能會阻礙獸用新型抗感染藥物的研發和創新，並影響市場成長。

全球獸用感染疾病物市場趨勢

全球獸用感染疾病物市場正經歷顯著的變化趨勢，這主要得益於寵物醫療保健需求的不斷成長。寵物飼主越來越重視預防保健和有效治療方法，從而推動了獸用感染疾病物使用的激增。寵物產品優質化、寵物主人與獸醫服務的互動日益頻繁以及對治療效果的期望不斷提高，進一步強化了這一趨勢。為了因應這些變化，生產商正致力於開發標靶製劑和便捷的給藥方式，同時增加對策略合作和獸醫及寵物飼主個性化教育計畫的投入。因此，品牌藥品和慢性病管理方案在獸藥領域的重要性日益凸顯。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球獸用感染疾病物市場規模：依產品類型分類

• 抗生素
  • 四環黴素
  • 青黴素
  • 頭孢菌素
  • 大環內酯類
  • 磺胺類藥物藥物
  • Fluoroquinolones
  • Aminoglycosides
  • 其他
• 抗病毒藥物
  • 牲畜抗病毒藥物
  • 伴侶動物抗病毒藥物
  • 其他
• 抗真菌藥物
  • 局部抗真菌藥物
  • 全身性抗真菌藥物
• 抗寄生蟲感染疾病物

全球獸用感染疾病物市場規模：依動物類型分類

• 伴侶動物
  • 狗
  • 貓
  • 馬
  • 其他
• 家畜
  • 牛
  • 家禽
  • 豬
  • 綿羊和山羊
  • 水產養殖
  • 其他

全球獸用感染疾病物市場規模：依給藥途徑分類

• 口服
• 注射藥物
• 外用
• 乳房內給藥
• 其他

全球獸用感染疾病物市場規模：依通路分類

• 獸醫醫院和診所
• 零售獸藥局
• 電子商務
• 飼料廠及農業供應店

全球獸用感染疾病物市場規模：依最終用戶分類

• 獸醫醫院和診所
• 畜牧場
• 寵物飼主
• 其他

全球獸用感染疾病物市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis
• Elanco Animal Health
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Ceva Sante Animale
• Virbac
• Vetoquinol
• Dechra Pharmaceuticals
• Phibro Animal Health
• Huvepharma
• Norbrook Laboratories
• HIPRA
• Bimeda
• Indian Immunologicals Limited
• Neogen Corporation
• Kyoritsu Seiyaku Corporation
• Endovac Animal Health
• Chanelle Pharma
• Ashish Life Science
• Zydus Animal Health

結論與建議

Global Veterinary Anti-Infectives Market size was valued at USD 8.6 Billion in 2024 and is poised to grow from USD 9.22 Billion in 2025 to USD 16.08 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The global veterinary anti-infectives market is primarily driven by the increasing demand for effective infection control in both livestock and companion animals. This market includes a variety of products such as antibiotics, antivirals, antifungals, and diagnostics that are crucial for maintaining animal health, which directly impacts food security, public health, and economic livelihoods. Growth in this sector is fueled by intensified farming practices and a rise in pet ownership, prompting pharmaceutical innovations and regulatory scrutiny. Key factors influencing market dynamics include the challenge of antimicrobial resistance and its implications for veterinary practices. As resistance escalates, there is a heightened demand for rapid diagnostics, narrow-spectrum agents, and alternative treatments, alongside advancements driven by AI that enhance diagnostics and antimicrobial stewardship.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Anti-Infectives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Anti-Infectives Market Segments Analysis

Global veterinary anti-infectives market is segmented by product type, animal type, route of administration, distribution channel, end user and region. Based on product type, the market is segmented into Antibiotics, Antivirals, Antifungals and Antiparasitic Anti-infectives. Based on animal type, the market is segmented into Companion Animals and Livestock Animals. Based on route of administration, the market is segmented into Oral, Injectable, Topical, Intramammary and Others. Based on distribution channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, E-commerce and Feed Mills & Agricultural Supply Stores. Based on end user, the market is segmented into Veterinary Hospitals & Clinics, Animal Farms, Pet Owners and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Anti-Infectives Market

One key market driver for the global veterinary anti-infectives market is the increasing prevalence of infectious diseases in livestock and companion animals. The rising awareness among pet owners and livestock producers about the health and welfare of animals has heightened the demand for effective treatments. Furthermore, regulatory developments aimed at enhancing animal health, combined with the growth in the livestock sector due to the demand for protein-rich food sources, create a substantial need for veterinary anti-infectives. Advancements in research and development of novel therapeutics are also contributing to market growth, addressing the challenges posed by antibiotic resistance and the need for alternative solutions.

Restraints in the Global Veterinary Anti-Infectives Market

One key market restraint for the global veterinary anti-infectives market is the increasing incidence of antimicrobial resistance (AMR). The rising prevalence of resistant bacterial strains in both human and veterinary medicine poses significant challenges to the efficacy of existing anti-infective treatments. This not only limits the options available for veterinarians in effectively managing infections but also raises concerns regarding public health and food safety. Regulatory bodies are increasingly scrutinizing the approval and use of antimicrobial agents, leading to stricter regulations and guidelines. These factors can hinder market growth and innovation in developing new anti-infective products for veterinary use.

Market Trends of the Global Veterinary Anti-Infectives Market

The Global Veterinary Anti-Infectives market is witnessing a significant trend fueled by the increasing demand for companion animal healthcare. Pet owners are increasingly prioritizing preventive care and effective treatment options, leading to a surge in the adoption of veterinary anti-infectives. This trend is further driven by the premiumization of pet products, heightened engagement with veterinary services, and rising expectations for treatment outcomes. In response, manufacturers are innovating with targeted formulations and convenient dosing methods, while also investing in strategic partnerships and tailored educational programs for veterinary practitioners and pet owners. As a result, branded therapeutics and chronic care pathways are gaining prominence in the veterinary pharmaceutical sector.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Veterinary Anti-infectives Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Antibiotics
  • Tetracyclines
  • Penicillins
  • Cephalosporins
  • Macrolides
  • Sulfonamides
  • Fluoroquinolones
  • Aminoglycosides
  • Others
• Antivirals
  • Livestock Antivirals
  • Companion Animal Antivirals
  • Others
• Antifungals
  • Topical Antifungals
  • Systemic Antifungals
• Antiparasitic Anti-infectives

Global Veterinary Anti-infectives Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others
• Livestock Animals
  • Cattle
  • Poultry
  • Swine
  • Sheep & Goats
  • Aquaculture
  • Others

Global Veterinary Anti-infectives Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Topical
• Intramammary
• Others

Global Veterinary Anti-infectives Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Veterinary Pharmacies
• E-commerce
• Feed Mills & Agricultural Supply Stores

Global Veterinary Anti-infectives Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Animal Farms
• Pet Owners
• Others

Global Veterinary Anti-infectives Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Route of Administration, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endovac Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chanelle Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashish Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations